StockNews.com Initiates Coverage on Global Cord Blood (NYSE:CO)

StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a report published on Sunday. The firm issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

NYSE CO opened at $0.90 on Friday. The firm’s 50 day moving average price is $0.95 and its two-hundred day moving average price is $1.22. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50. The stock has a market cap of $109.40 million, a price-to-earnings ratio of 1.41 and a beta of 0.16.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.